THRX 12.99 Theravance $THRX Hit a 52 week low of 12.78

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
THRX 12.99 Theravance $THRX Hit a 52 week low of 12.78 Closing the day 10:44 at 12.99 +0.06 +0.46% With a day low of 12.78 and a total volume of 87,058.

THRX Recent Posts: http://investorshangout.com/Theravance-THRX-55637/

THRX Theravance Recent Headline News

When Is It Time To Accumulate Theravance?
Chris Lau - at Seeking Alpha - Tue Nov 11, 10:50AM CST

MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), THRX: 13.00 (+0.07), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33)

Sanofi/Regeneron asthma drug successful in Phase 2 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 6:44AM CST

MRK: 59.20 (-0.17), AZN: 74.10 (-0.10), AMGN: 161.33 (-1.09), TEVA: 58.13 (-0.06), THRX: 13.00 (+0.07), GSK: 45.63 (-0.33), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)

Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:20AM CST
Theravance Biopharma reported a third-quarter 2014 loss of $1.72 per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)

Shares of THRX Down 47.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:10AM CST
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 4 months, Theravance has returned 47.93% as of today's recent price of $14.23.
THRX: 13.00 (+0.07)

5 Stocks With Big Insider Buying in November: NuStar, Huntsman and More
at The Street - Thu Nov 06, 11:45AM CST
Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.
SCCO: 30.08 (-0.15), WRLD: 76.38 (-1.16), NS: 60.10 (-0.62), THRX: 13.00 (+0.07), HUN: 24.76 (-0.43)

Theravance to Present at Two Upcoming Investor Conferences in November
Marketwired - Wed Nov 05, 3:08PM CST
Theravance, Inc. (NASDAQ: THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)

Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 34.76 (+0.47), TJX: 63.46 (+0.21), NKE: 94.78 (-0.10), TGT: 66.08 (+0.36), WMT: 79.06 (+0.05), HBI: 109.54 (+0.65), THRX: 13.00 (+0.07), KORS: 69.82 (+0.93), GPS: 38.78 (-0.04), RL: 170.49 (-0.58), LULU: 44.07 (+0.89)

InsiderInsights.com Daily Round Up 11/4/14: UFI, SABA, CCI
InsiderInsights - at Seeking Alpha - Wed Nov 05, 8:31AM CST

CCI: 79.92 (+0.31), CBG: 32.54 (-0.10), HGG: 5.63 (-0.05), LLY: 67.44 (-0.41), BA: 125.45 (+0.09), MAR: 76.80 (-0.34), QNST: 4.17 (-0.16), OZRK: 36.41 (-0.01), APO: 22.93 (-0.59), STAA: 8.85 (-0.02), AMBR: 11.29 (-0.15), FSAM: 13.67 (+0.14), WRLD: 76.38 (-1.16), CPLA: 69.01 (+0.43), THRX: 13.00 (+0.07), MSFT: 48.71 (-0.16), UFI: 27.10 (-0.42), AN: 58.11 (+0.24), CRM: 63.35 (-0.71)

FDA accepts BI's Spiriva NDA for asthma
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:06PM CST

AZN: 74.10 (-0.10), TEVA: 58.13 (-0.06), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53), REGN: 399.83 (+1.47), NVS: 92.69 (-0.08)

7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST

KND: 20.53 (+0.04), VIVO: 16.99 (+0.08), PETS: 13.66 (+0.06), PFE: 30.45 (+0.13), GSK: 45.63 (-0.33), MR: 31.17 (+0.31), SEM: 13.58 (+0.04), PDLI: 8.02 (-0.09), SNN: 33.48 (-0.43), AZN: 74.10 (-0.10), MRK: 59.21 (-0.16), STJ: 65.27 (-0.51), TRIB: 18.12 (-0.14), ABBV: 63.84 (-0.01), THRX: 13.00 (+0.07), SNY: 46.61 (-0.53)

Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:10AM CST
Theravance reported third-quarter 2014 loss of 19 cents per share.
AMAG: 34.74 (-0.14), TBPH: 17.63 (-0.33), GSK: 45.63 (-0.33), THRX: 13.00 (+0.07)

Bayer Q3 Earnings Grow Y/Y on New Product Sales, View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:00AM CST
Bayer's (BAYRY) earnings during the third quarter of 2014 came in at roughly $1.79 per share.
MRK: 59.21 (-0.16), AMAG: 34.74 (-0.14), THRX: 13.00 (+0.07)

Update: GSK Starts Promoting Theravance Drugs More Actively
Early Retiree - at Seeking Alpha - Sat Nov 01, 7:42AM CDT

THRX: 13.00 (+0.07), GSK: 45.63 (-0.33)

More on Theravance Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 1:03PM CDT

THRX: 13.00 (+0.07)

Theravance misses Street 3Q forecasts
Automated Insights - Fri Oct 31, 4:04AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) _ Theravance Inc. (THRX) on Friday reported a third-quarter loss of $21.3 million.
THRXV: 28.00 (+7.07), THRX: 13.00 (+0.07)

Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 10:27PM CDT

THRX: 13.00 (+0.07)

Theravance declares $0.25 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:49PM CDT

THRX: 13.00 (+0.07)

Theravance Has Returned 40.7% Since SmarTrend Recommendation (THRX)
Comtex SmarTrend(R) - Thu Oct 30, 4:38PM CDT
SmarTrend identified a Downtrend for Theravance (NASDAQ:THRX) on July 18th, 2014 at $27.33. In approximately 3 months, Theravance has returned 40.69% as of today's recent price of $16.21.
THRX: 13.00 (+0.07)

Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:55PM CDT

THRX: 13.00 (+0.07)

Theravance misses by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:26PM CDT

THRX: 13.00 (+0.07)

Innoviva, Inc. (INVA) Stock Research Links

INVA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 1

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Getac’s B360X Pro: Pushing AI to New Extremes

Updated Category News Views 3

A Technological Game-Changer from Getac Every so often, a piece of tech arrives that sends ripples through the sector. Getac’s next-gen B360X and B360X Pro are exactly that. These machines aren’t your average laptops—they’re built to butcher bad conditions while harnessing some mean AI power. Trust me, these aren't merely updates; they’ve got some serious DNA...

Continue Reading
One Times Square Candy Experience Offers Unique Halloween

Updated Category News Views 10

Halloween Takes Over Times Square A cold October breeze and you find One Times Square turning a new page. Forget the usual New Year's Ball hype. This time, they're throwing a Halloween bash that you haven't seen before. Kicking off October 24, the One Times Square Candy Experience is transforming itself into a sugary wonderland right in Manhattan's bustling heart. For a...

Continue Reading
SAGA Metals Strikes Potential with Wolverine Drilling Program

Updated Category News Views 6

Drilling for Treasure in Labrador's Rich Earth Hey, ever felt that gritty thrill in your bones? That's what I imagine SAGA Metals must be feeling right now. When you're out there punching holes into Mother Earth hoping to hit pay dirt, and every single one of those holes hits something juicy—trust me, that's like hitting the jackpot before even knowing the lottery...

Continue Reading
Pearl Meyer Bolsters Leadership Team with Key Additions

Updated Category News Views 6

In the fast-paced world of executive advising, Pearl Meyer just cranked up the heat, announcing the addition of four seasoned managing directors to their Leadership Advisory practice. These new folks are here to shake things up, with a strong focus on executive assessment, leadership effectiveness, and organizational transformation. Strategic Moves in Leadership Adding...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 4

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
Lazard's Q3 2026: Surging Revenue, Waning Net Income

Updated Category News Views 3

Breaking Down the Numbers Lazard just dropped its Q3 2026 earnings report, and you can smell both optimism and caution in the air. Sure, $814 million in net revenue isn’t anything to sneeze at, especially when it’s a neat 9% jump from last year’s $748 million. Adjusted figures were a whisker away at $805 million. But dig deeper, and things get a tad less rosy—net...

Continue Reading
JiMMYBAR! Expands Military Retail Footprint Globally

Updated Category News Views 0

Proteins and Military: A New Rollout Out of the blue, JiMMYBAR! is shaking things up by beefing up their military retail footprint with America's FIRST Creatine + Protein Bar. What's driving this charge? A leap from just promises to actually stocking shelves in 149 military locations worldwide. From home base in the good ol' U.S. of A. to as far-flung as South Korea,...

Continue Reading
Shareholder M&A Alert: Is the Deal Fair?

Updated Category News Views 5

A Closer Look at the Deals in Question It seems every other day another company’s deciding to shack up with a new partner, but are those deals really all they’re cracked up to be? Here’s a rundown of some fresh cases launching shareholder class actions probing the fairness of recent transactions. Big names on the list? Bowman Consulting, DoubleVerify, Varex Imaging,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 6

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading

Top 5 Most Recently Viewed Articles

The Astonishing Value Growth of Acuity Inc Over 20 Years

Updated Category News Views 163

The Astonishing Value Growth of Acuity Inc Over 20 Years Acuity Inc (AYI) has demonstrated an exceptional performance in the stock market over the past two decades, significantly outpacing the overall market with an annualized return of 12.88%. With a current market capitalization of approximately $10.40 billion, Acuity has proven to be a sound investment choice for many....

Continue Reading
Protext Mobility's CEO Shares Vision After Caveat Emptor Lift

Updated Category News Views 146

Protext Mobility's Strategic Shift and Future Vision Protext Mobility, Inc. (OTC: TXTM), a notable player in the biotechnology sector, is forging ahead with a renewed focus on plant-based therapeutics. Recently, the company announced the removal of the Caveat Emptor designation, marking a significant milestone in its operational journey. This change has prompted an...

Continue Reading
Crown Electrokinetics Gains Ground with $33M Lead Pipe Contracts

Updated Category News Views 161

Exciting Contracts for Crown Electrokinetics Crown Electrokinetics Corp. (NASDAQ: CRKN) has recently made headlines by securing significant contracts in the lead pipe remediation field, amounting to a remarkable total of $33 million. This achievement marks a strategic shift for the company as it delves into a crucial area of infrastructure improvement, tackling the...

Continue Reading
Join the Investigation: Camping World Holdings, Inc. Case

Updated Category News Views 141

Understanding the Investigation into Camping World Holdings, Inc. There’s an ongoing investigation concerning Camping World Holdings, Inc. (NYSE: CWH) that has caught the attention of investors and legal experts alike. The Schall Law Firm, known for its advocacy on behalf of shareholders, has stepped forward to lead this inquiry. This opportunity arises for those who...

Continue Reading
Celebrating Compassion: How Nurses Enhance Senior Care Services

Updated Category News Views 147

Celebrating Compassion: How Nurses Enhance Senior Care Services During National Nurses Week, an important time to honor the dedication of nurses, Assisted Living Locators stands out by showcasing the tremendous impact that its franchise owners, many of whom are former nurses, are making in the senior care sector. The significance of having knowledgeable individuals in...

Continue Reading